JP2007527416A - ペルオキシソーム増殖因子活性化受容体（ｐｐａｒ）二重作動薬として有用なフェノキシ酢酸誘導体 - Google Patents
ペルオキシソーム増殖因子活性化受容体（ｐｐａｒ）二重作動薬として有用なフェノキシ酢酸誘導体 Download PDFInfo
- Publication number
- JP2007527416A JP2007527416A JP2006538316A JP2006538316A JP2007527416A JP 2007527416 A JP2007527416 A JP 2007527416A JP 2006538316 A JP2006538316 A JP 2006538316A JP 2006538316 A JP2006538316 A JP 2006538316A JP 2007527416 A JP2007527416 A JP 2007527416A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenyl
- thiadiazol
- phenoxy
- propionic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *c(c(Cl)c1)ccc1-c1n[s]c(CBr)n1 Chemical compound *c(c(Cl)c1)ccc1-c1n[s]c(CBr)n1 0.000 description 3
- UXEPVZPDCHIGDL-UHFFFAOYSA-N CC(C)(C(O)=O)Oc(c(C)c1)ccc1OCc1nc(-c2cc(Cl)c(C)cc2)n[s]1 Chemical compound CC(C)(C(O)=O)Oc(c(C)c1)ccc1OCc1nc(-c2cc(Cl)c(C)cc2)n[s]1 UXEPVZPDCHIGDL-UHFFFAOYSA-N 0.000 description 1
- VNJJEMOMRQCJFH-UHFFFAOYSA-N CC(C)(C(O)=O)Oc(c(C)c1)ccc1OCc1nc(-c2ccc(C(F)(F)F)cc2)n[s]1 Chemical compound CC(C)(C(O)=O)Oc(c(C)c1)ccc1OCc1nc(-c2ccc(C(F)(F)F)cc2)n[s]1 VNJJEMOMRQCJFH-UHFFFAOYSA-N 0.000 description 1
- VPSDUDCUKRKSEV-UHFFFAOYSA-N CC(C)(C(O)=O)Oc(cc1)c(C)cc1S(Cc1nc(-c(cc2)cc(Cl)c2Cl)n[s]1)=O Chemical compound CC(C)(C(O)=O)Oc(cc1)c(C)cc1S(Cc1nc(-c(cc2)cc(Cl)c2Cl)n[s]1)=O VPSDUDCUKRKSEV-UHFFFAOYSA-N 0.000 description 1
- BIEZLHAQUMPLCK-UHFFFAOYSA-N CC(C)(C(O)=O)Oc(cc1)c(C)cc1SCc1nc(-c2ccc(C)c(C)c2)n[s]1 Chemical compound CC(C)(C(O)=O)Oc(cc1)c(C)cc1SCc1nc(-c2ccc(C)c(C)c2)n[s]1 BIEZLHAQUMPLCK-UHFFFAOYSA-N 0.000 description 1
- QKPRBQKBZSCFSF-UHFFFAOYSA-N CC(C)(C(O)=O)Oc(cc1)c(C)cc1SCc1nc(-c2ccc(C)c(Cl)c2)n[s]1 Chemical compound CC(C)(C(O)=O)Oc(cc1)c(C)cc1SCc1nc(-c2ccc(C)c(Cl)c2)n[s]1 QKPRBQKBZSCFSF-UHFFFAOYSA-N 0.000 description 1
- YKWIOXRRYMYYDL-IADYIPOJSA-N CCCC(CSc(cc1)cc(C)c1OC(C)(C)C(O)=O)/N=C(/c(cc1)ccc1OC(F)(F)F)\SC Chemical compound CCCC(CSc(cc1)cc(C)c1OC(C)(C)C(O)=O)/N=C(/c(cc1)ccc1OC(F)(F)F)\SC YKWIOXRRYMYYDL-IADYIPOJSA-N 0.000 description 1
- WAPHCUDWEMBULI-UHFFFAOYSA-N CCOC(C(C)(C)Oc(c(C)c1)ccc1OC(C)=O)=O Chemical compound CCOC(C(C)(C)Oc(c(C)c1)ccc1OC(C)=O)=O WAPHCUDWEMBULI-UHFFFAOYSA-N 0.000 description 1
- NWZQBQASCXHTBK-UHFFFAOYSA-N CCOC(C(C)(C)Oc(cc1)c(C)cc1OCc1nc(-c(cc2Cl)ccc2OC(F)(F)F)n[s]1)=O Chemical compound CCOC(C(C)(C)Oc(cc1)c(C)cc1OCc1nc(-c(cc2Cl)ccc2OC(F)(F)F)n[s]1)=O NWZQBQASCXHTBK-UHFFFAOYSA-N 0.000 description 1
- CEAYLRXCIZAIPQ-UHFFFAOYSA-N O=C1SN=C(c(c(Cl)c2)ccc2Cl)O1 Chemical compound O=C1SN=C(c(c(Cl)c2)ccc2Cl)O1 CEAYLRXCIZAIPQ-UHFFFAOYSA-N 0.000 description 1
- XBOOZGOLGRBBAU-UHFFFAOYSA-N OCc1n[s]c(-c(cc2Cl)ccc2Cl)n1 Chemical compound OCc1n[s]c(-c(cc2Cl)ccc2Cl)n1 XBOOZGOLGRBBAU-UHFFFAOYSA-N 0.000 description 1
- GUSNCFMLCDWTTI-UHFFFAOYSA-N OCc1n[s]c(-c2ccc(C(F)(F)F)cc2)n1 Chemical compound OCc1n[s]c(-c2ccc(C(F)(F)F)cc2)n1 GUSNCFMLCDWTTI-UHFFFAOYSA-N 0.000 description 1
- RJSAGKWMYSYKHM-UHFFFAOYSA-N OCc1nc(-c2ccc(C(F)(F)F)cc2)n[s]1 Chemical compound OCc1nc(-c2ccc(C(F)(F)F)cc2)n[s]1 RJSAGKWMYSYKHM-UHFFFAOYSA-N 0.000 description 1
- BXAVKNRWVKUTLY-UHFFFAOYSA-N Oc(cc1)ccc1S Chemical compound Oc(cc1)ccc1S BXAVKNRWVKUTLY-UHFFFAOYSA-N 0.000 description 1
- CEPVDEFFGUESDM-UHFFFAOYSA-N Oc(cc1)ccc1SCc1nc(C(CC2)=CC=C2C(F)(F)F)n[s]1 Chemical compound Oc(cc1)ccc1SCc1nc(C(CC2)=CC=C2C(F)(F)F)n[s]1 CEPVDEFFGUESDM-UHFFFAOYSA-N 0.000 description 1
- FYWROFXFKCCHJU-UHFFFAOYSA-N Oc1ccc(CSCc2nc(-c3ccc(C(F)(F)F)cc3)n[s]2)cc1 Chemical compound Oc1ccc(CSCc2nc(-c3ccc(C(F)(F)F)cc3)n[s]2)cc1 FYWROFXFKCCHJU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51656103P | 2003-10-31 | 2003-10-31 | |
| PCT/US2004/036028 WO2005041959A1 (en) | 2003-10-31 | 2004-10-28 | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007527416A true JP2007527416A (ja) | 2007-09-27 |
| JP2007527416A5 JP2007527416A5 (https=) | 2007-12-06 |
Family
ID=34549548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538316A Withdrawn JP2007527416A (ja) | 2003-10-31 | 2004-10-28 | ペルオキシソーム増殖因子活性化受容体（ｐｐａｒ）二重作動薬として有用なフェノキシ酢酸誘導体 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US7015329B2 (https=) |
| EP (1) | EP1684752B1 (https=) |
| JP (1) | JP2007527416A (https=) |
| KR (1) | KR20060109925A (https=) |
| CN (1) | CN1897939A (https=) |
| AR (1) | AR046311A1 (https=) |
| AT (1) | ATE362367T1 (https=) |
| AU (1) | AU2004285530A1 (https=) |
| BR (1) | BRPI0416106A (https=) |
| CA (1) | CA2544317A1 (https=) |
| CR (1) | CR8377A (https=) |
| DE (1) | DE602004006529T2 (https=) |
| EA (1) | EA009804B1 (https=) |
| EC (1) | ECSP066536A (https=) |
| ES (1) | ES2287786T3 (https=) |
| IL (1) | IL175310A0 (https=) |
| NO (1) | NO20062511L (https=) |
| TW (1) | TW200528438A (https=) |
| UA (1) | UA84035C2 (https=) |
| WO (1) | WO2005041959A1 (https=) |
| ZA (1) | ZA200604420B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005042478A2 (en) | 2003-09-19 | 2005-05-12 | Janssen Pharmaceutica, N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| JP2007527416A (ja) * | 2003-10-31 | 2007-09-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ペルオキシソーム増殖因子活性化受容体（ｐｐａｒ）二重作動薬として有用なフェノキシ酢酸誘導体 |
| WO2006042245A1 (en) * | 2004-10-11 | 2006-04-20 | Dr. Reddy's Laboratories Ltd. | Novel isoxazole compounds having ppar agonist activity |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| PE20080188A1 (es) | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
| CA2663115C (en) | 2006-09-08 | 2015-04-28 | Rhode Island Hospital | Treatment, prevention, and reversal of alcohol-induced liver disease |
| WO2008030604A2 (en) | 2006-09-08 | 2008-03-13 | Rhode Island Hospital | Treatment, prevention, and reversal of alcohol-induced brain disease |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| EP3053440B1 (en) | 2007-04-11 | 2020-08-12 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US8461183B2 (en) * | 2008-05-26 | 2013-06-11 | Genfit | PPAR agonist compounds, preparation and uses |
| JP5996532B2 (ja) | 2010-07-15 | 2016-09-21 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 有害生物防除剤としての新規複素環式化合物 |
| EP2612669A4 (en) | 2010-08-31 | 2014-05-14 | Snu R&Db Foundation | USING THE FÖTAL REPROGRAMMING OF A PPAR AGONIST |
| BR112013009823A2 (pt) | 2010-10-22 | 2016-07-05 | Bayer Ip Gmbh | novos compostos heterocíclicos como pesticidas |
| SI2841437T1 (sl) | 2012-04-26 | 2017-09-29 | Bristol-Myers Squibb Company | Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov |
| CA2871640A1 (en) | 2012-04-26 | 2013-10-31 | Bristol-Myers Squibb Company | Par4 agonist peptides |
| KR102750722B1 (ko) * | 2022-03-16 | 2025-01-09 | 재단법인 대구경북첨단의료산업진흥재단 | 싸이아다이아졸 화합물 및 이를 포함하는 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| WO2024153134A1 (zh) * | 2023-01-18 | 2024-07-25 | 哈尔滨三联药业股份有限公司 | 五元杂环类化合物及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE451346T1 (de) * | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| US6242493B1 (en) | 1998-03-13 | 2001-06-05 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| AU4167099A (en) | 1998-06-19 | 2000-01-05 | Nissan Chemical Industries Ltd. | Heterocyclic compounds as hypoglycemic agents |
| AUPP609198A0 (en) | 1998-09-22 | 1998-10-15 | Curtin University Of Technology | Use of non-peptidyl compounds for the treatment of insulin related ailments |
| PL351470A1 (en) | 1999-04-28 | 2003-04-22 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as ppar receptor ligands |
| YU72201A (sh) | 1999-04-28 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | Derivati di-aril kiseline kao ppar receptorski ligandi |
| US6417212B1 (en) * | 1999-08-27 | 2002-07-09 | Eli Lilly & Company | Modulators of peroxisome proliferator activated receptors |
| EP1310494B1 (en) * | 2000-08-11 | 2012-01-25 | Nippon Chemiphar Co., Ltd. | PPAR (delta) ACTIVATORS |
| US6875780B2 (en) * | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| EP1578715B1 (en) | 2002-12-20 | 2011-03-02 | Bayer Pharmaceuticals Corporation | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| JP2007527416A (ja) * | 2003-10-31 | 2007-09-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ペルオキシソーム増殖因子活性化受容体（ｐｐａｒ）二重作動薬として有用なフェノキシ酢酸誘導体 |
-
2004
- 2004-10-28 JP JP2006538316A patent/JP2007527416A/ja not_active Withdrawn
- 2004-10-28 BR BRPI0416106-8A patent/BRPI0416106A/pt not_active IP Right Cessation
- 2004-10-28 US US10/975,785 patent/US7015329B2/en not_active Expired - Fee Related
- 2004-10-28 CN CNA2004800382161A patent/CN1897939A/zh active Pending
- 2004-10-28 EA EA200600878A patent/EA009804B1/ru not_active IP Right Cessation
- 2004-10-28 AU AU2004285530A patent/AU2004285530A1/en not_active Abandoned
- 2004-10-28 DE DE602004006529T patent/DE602004006529T2/de not_active Expired - Fee Related
- 2004-10-28 ES ES04796767T patent/ES2287786T3/es not_active Expired - Lifetime
- 2004-10-28 EP EP04796767A patent/EP1684752B1/en not_active Expired - Lifetime
- 2004-10-28 KR KR1020067010610A patent/KR20060109925A/ko not_active Withdrawn
- 2004-10-28 CA CA002544317A patent/CA2544317A1/en not_active Abandoned
- 2004-10-28 UA UAA200605139A patent/UA84035C2/ru unknown
- 2004-10-28 WO PCT/US2004/036028 patent/WO2005041959A1/en not_active Ceased
- 2004-10-28 AT AT04796767T patent/ATE362367T1/de not_active IP Right Cessation
- 2004-10-29 AR ARP040103979A patent/AR046311A1/es not_active Application Discontinuation
- 2004-10-29 TW TW093132849A patent/TW200528438A/zh unknown
-
2005
- 2005-11-15 US US11/274,656 patent/US7498351B2/en not_active Expired - Fee Related
-
2006
- 2006-04-27 IL IL175310A patent/IL175310A0/en unknown
- 2006-04-28 EC EC2006006536A patent/ECSP066536A/es unknown
- 2006-05-02 CR CR8377A patent/CR8377A/es unknown
- 2006-05-30 ZA ZA200604420A patent/ZA200604420B/en unknown
- 2006-05-31 NO NO20062511A patent/NO20062511L/no not_active Application Discontinuation
-
2009
- 2009-01-23 US US12/358,703 patent/US20090131489A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050096362A1 (en) | 2005-05-05 |
| AU2004285530A1 (en) | 2005-05-12 |
| CN1897939A (zh) | 2007-01-17 |
| TW200528438A (en) | 2005-09-01 |
| KR20060109925A (ko) | 2006-10-23 |
| NO20062511L (no) | 2006-07-27 |
| US20090131489A1 (en) | 2009-05-21 |
| WO2005041959A1 (en) | 2005-05-12 |
| ECSP066536A (es) | 2006-12-20 |
| EA009804B1 (ru) | 2008-04-28 |
| IL175310A0 (en) | 2006-09-05 |
| ATE362367T1 (de) | 2007-06-15 |
| US7015329B2 (en) | 2006-03-21 |
| BRPI0416106A (pt) | 2007-01-02 |
| AR046311A1 (es) | 2005-11-30 |
| DE602004006529T2 (de) | 2008-01-31 |
| DE602004006529D1 (de) | 2007-06-28 |
| US20060074246A1 (en) | 2006-04-06 |
| US7498351B2 (en) | 2009-03-03 |
| UA84035C2 (ru) | 2008-09-10 |
| EP1684752B1 (en) | 2007-05-16 |
| EA200600878A1 (ru) | 2006-10-27 |
| CR8377A (es) | 2008-11-24 |
| ES2287786T3 (es) | 2007-12-16 |
| ZA200604420B (en) | 2007-10-31 |
| CA2544317A1 (en) | 2005-05-12 |
| EP1684752A1 (en) | 2006-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090131489A1 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| US7301050B2 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| US8242173B2 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| US7875744B2 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| NO337041B1 (no) | 4-((fenoksyalkyl)tio)-fenoksyeddiksyrer og analoger, farmasøytisk preparat samt anvendelse av forbindelsene | |
| MXPA06004897A (en) | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists | |
| HK1104523B (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| HK1101758B (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071017 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071017 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080202 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20090417 |